{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:33:15Z","timestamp":1791433995039,"version":"4.3.3"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim Pharma GmbH und Co. KG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Basic to Translational Science"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jacbts.2026.101587","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T01:48:58Z","timestamp":1780710538000},"page":"101587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Synergistic Effects of SGLT2 Inhibitors and GLP-1R Agonists on Inflammation-Associated Oxidative Stress in Atrial Fibrillation"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1998-499X","authenticated-orcid":false,"given":"Walaa","family":"Fakih","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Mroueh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4737-9882","authenticated-orcid":false,"given":"Shinnosuke","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halim","family":"Marzak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said","family":"Amissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dal-Seong","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Kerth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Kindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Mommerot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Paul","family":"Pieper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Ohlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7295-3041","authenticated-orcid":false,"given":"Olivier","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9997-9287","authenticated-orcid":false,"given":"Val\u00e9rie","family":"Schini-Kerth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4742-3740","authenticated-orcid":false,"given":"Laurence","family":"Jesel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jacbts.2026.101587_bib1","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/CIRCEP.107.754564","article-title":"Atrial remodeling and atrial fibrillation: mechanisms and implications","volume":"1","author":"Nattel","year":"2008","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"5","key":"10.1016\/j.jacbts.2026.101587_bib2","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1253\/circj.CJ-12-1155","article-title":"Role of tumor necrosis factor-\u03b1 in the pathogenesis of atrial fibrosis and development of an arrhythmogenic substrate","volume":"77","author":"Liew","year":"2013","journal-title":"Circ. J"},{"key":"10.1016\/j.jacbts.2026.101587_bib3","series-title":"Sodium-Glucose Transport Protein 2 (SGLT2) Inhibitors","author":"Padda","year":"2023"},{"issue":"1","key":"10.1016\/j.jacbts.2026.101587_bib4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12933-022-01552-2","article-title":"Putative protective effects of sodium-glucose cotransporter 2 inhibitors on atrial fibrillation through risk factor modulation and off-target actions: potential mechanisms and future directions","volume":"21","author":"Shetty","year":"2022","journal-title":"Cardiovas Diabetol"},{"issue":"1","key":"10.1016\/j.jacbts.2026.101587_bib5","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jtha.2023.09.022","article-title":"COVID-19 promotes endothelial dysfunction and thrombogenicity: role of proinflammatory cytokines\/SGLT2 prooxidant pathway","volume":"22","author":"Mroueh","year":"2024","journal-title":"J Thromb Haemost"},{"issue":"18","key":"10.1016\/j.jacbts.2026.101587_bib6","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.3390\/jcm13185408","article-title":"The role of sodium glucose co-transporter 2 inhibitors in atrial fibrillation: a comprehensive review","volume":"13","author":"Stachteas","year":"2024","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.jacbts.2026.101587_bib7","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/jce.16544","article-title":"Impact of sodium-glucose co-transporter 2 inhibitors on atrial fibrillation recurrence post-catheter ablation among patients with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"36","author":"Abdelhadi","year":"2025","journal-title":"J Cardiovas Electrophysiol"},{"issue":"17","key":"10.1016\/j.jacbts.2026.101587_bib8","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.jacc.2024.08.023","article-title":"Atrial fibrillation and semaglutide effects in obesity-related heart failure with preserved ejection fraction: STEP-HFpEF program","volume":"84","author":"Verma","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"10.1016\/j.jacbts.2026.101587_bib9","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.jacc.2024.08.021","article-title":"Effect of semaglutide on cardiac structure and function in patients with obesity-related heart failure","volume":"84","author":"Solomon","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.jacbts.2026.101587_bib10","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1007\/s00011-024-01950-0","article-title":"Cyclic adenosine monophosphate critically modulates cardiac GLP-1 receptor\u2019s anti-inflammatory effects","volume":"73","author":"Stoicovy","year":"2024","journal-title":"Inflamm Res"},{"issue":"8","key":"10.1016\/j.jacbts.2026.101587_bib11","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1111\/dom.14399","article-title":"Glucagon-like peptide-1 receptor agonists improve biomarkers of inflammation and oxidative stress: a systematic review and meta-analysis of randomised controlled trials","volume":"23","author":"Bray","year":"2021","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"10.1016\/j.jacbts.2026.101587_bib12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s40471-017-0131-y","article-title":"Propensity scores in pharmacoepidemiology: beyond the horizon","volume":"4","author":"Jackson","year":"2017","journal-title":"Curr Epidemiol Rep"},{"key":"10.1016\/j.jacbts.2026.101587_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54296-w","article-title":"Large-scale single-nuclei profiling identifies a role for ATRNL1 in atrial fibrillation","volume":"15","author":"Hill","year":"2024","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.jacbts.2026.101587_bib14","article-title":"Vascular inflammation and oxidative stress: major triggers for cardiovascular disease","volume":"2019","author":"Steven","year":"2019","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"10.1016\/j.jacbts.2026.101587_bib15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/ijms19010026","article-title":"Effects of glucagon-like peptide-1 on oxidative stress and Nrf2 signaling","volume":"19","author":"Oh","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.jacbts.2026.101587_bib16","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/cvr\/cvae101","article-title":"Activated factor x xstimulates atrial endothelial cells and tissues to promote remodelling responses through AT1R\/NADPH oxidases\/SGLT1\/2","volume":"120","author":"Fakih","year":"2024","journal-title":"Cardiovasc Res"},{"issue":"10","key":"10.1016\/j.jacbts.2026.101587_bib17","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.3390\/jcm8101570","article-title":"Thrombin induces angiotensin II-mediated senescence in atrial endothelial cells: impact on pro-remodeling patterns","volume":"8","author":"Hasan","year":"2019","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.jacbts.2026.101587_bib18","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/cvr\/cvae257","article-title":"SGLT2 expression in human vasculature and heart correlates with low-grade inflammation and causes eNOS-NO\/ROS imbalance","volume":"121","author":"Mroueh","year":"2025","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2026.101587_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-021-01252-3","article-title":"Angiotensin II-induced upregulation of SGLT1 and 2 contributes to human microparticle-stimulated endothelial senescence and dysfunction: protective effect of gliflozins","volume":"20","author":"Park","year":"2021","journal-title":"Cardiovasc Diabetol"},{"issue":"35","key":"10.1016\/j.jacbts.2026.101587_bib20","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1093\/eurheartj\/ehae472","article-title":"Single-nucleus RNA sequencing identifies cell-type\u2013specific effects of sodium-glucose co-transporter 2 inhibitors in human myocardial slices","volume":"45","author":"Schmidt","year":"2024","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.jacbts.2026.101587_bib21","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.7150\/thno.66456","article-title":"Plaque-targeted, proteolysis-resistant, activatable and MRI-visible nano-GLP-1 receptor agonist targets smooth muscle cell differentiation in atherosclerosis","volume":"12","author":"Maiseyeu","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.jacbts.2026.101587_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103468","article-title":"Liraglutide and GLP-1 (9\u201337) alleviated hepatic ischemia-reperfusion injury by inhibiting ferroptosis via GSK3\u03b2\/Nrf2 pathway and SMAD159\/Hepcidin\/FTH pathway","volume":"79","author":"Lu","year":"2025","journal-title":"Redox Biol"},{"key":"10.1016\/j.jacbts.2026.101587_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109224","article-title":"Liraglutide protects high glucose-stimulated fibroblasts by activating the CD36-JNK-AP1 pathway to downregulate P4HA1","volume":"118","author":"Zhao","year":"2019","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"10.1016\/j.jacbts.2026.101587_bib24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/1074248420942007","article-title":"Liraglutide attenuates myocardial fibrosis via inhibition of AT1R-mediated ROS production in hypertensive mice","volume":"26","author":"Chen","year":"2021","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.jacbts.2026.101587_bib25","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s12012-020-09567-5","article-title":"Exendin-4 ameliorates cardiac remodeling in experimentally induced myocardial infarction in rats by inhibiting PARP1\/NF-\u03baB Axis in A SIRT1-dependent mechanism","volume":"20","author":"Eid","year":"2020","journal-title":"Cardiovasc Toxicol"},{"key":"10.1016\/j.jacbts.2026.101587_bib26","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00210-015-1124-3","article-title":"Exenatide (a GLP-1 agonist) improves the antioxidative potential of in vitro cultured human monocytes\/macrophages","volume":"388","author":"Bu\u0142dak","year":"2015","journal-title":"Naunyn Schmiedeb Arch Pharmacol"},{"issue":"4","key":"10.1016\/j.jacbts.2026.101587_bib27","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvz042","article-title":"Effects of semaglutide versus dulaglutide on epicardial fat thickness in subjects with type 2 diabetes and obesity","volume":"4","author":"Iacobellis","year":"2020","journal-title":"J Endocr Soc"},{"issue":"11","key":"10.1016\/j.jacbts.2026.101587_bib28","doi-asserted-by":"crossref","first-page":"E947","DOI":"10.1152\/ajpendo.00400.2015","article-title":"Exenatide exerts direct protective effects on endothelial cells through the AMPK\/Akt\/eNOS pathway in a GLP-1 receptor-dependent manner","volume":"310","author":"Wei","year":"2016","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jacbts.2026.101587_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078242","article-title":"Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study","volume":"385","author":"Simms-Williams","year":"2024","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.jacbts.2026.101587_bib30","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S2213-8587(19)30066-X","article-title":"Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial","volume":"7","author":"Zinman","year":"2019","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["JACC: Basic to Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X26001063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X26001063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T18:30:53Z","timestamp":1785177053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452302X26001063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2452302X26001063"],"URL":"https:\/\/doi.org\/10.1016\/j.jacbts.2026.101587","relation":{},"ISSN":["2452-302X"],"issn-type":[{"value":"2452-302X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic Effects of SGLT2 Inhibitors and GLP-1R Agonists on Inflammation-Associated Oxidative Stress in Atrial Fibrillation","name":"articletitle","label":"Article Title"},{"value":"JACC: Basic to Translational Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacbts.2026.101587","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"101587"}}